Australis Capital Inc. (AUSAF)
Australis Capital Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,783. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -661.5%. Its beta of -0.34 implies it has historically moved less than the broad market.
Australis Capital Inc. functions as a cannabis enterprise, actively pursuing both cannabis and horticultural ventures. These projects span a broad international landscape, encompassing the United States, Canada, Denmark, Finland, Iceland, Germany, the Netherlands, Bahrain, the United Arab Emirates, Southeast Asia, Australia, and numerous other global territories. The firm's corporate offices are located in Las Vegas, Nevada.
Australis Capital Inc. is most often compared with the following Healthcare names: